DU
LLY icon

Delphia (USA)’s Eli Lilly LLY Stock Holding History

Delphia (USA)’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,319
Closed -$619K – 93
2023
Q2 		$619K Sell
1,319
-105
-7% -$44K 0.98% 12
2023
Q1 		$489K Buy
1,424
+71
+5% +$23.9K 0.6% 38
2022
Q4 		$495K Buy
1,353
+313
+30% +$111K 0.57% 47
2022
Q3 		$336K Sell
1,040
-2,006
-66% -$636K 0.38% 90
2022
Q2 		$988K Buy
3,046
+254
+9% +$76.2K 0.68% 20
2022
Q1 		$800K Buy
2,792
+865
+45% +$223K 0.6% 27
2021
Q4 		$532K Buy
+1,927
New +$488K 0.57% 34

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Delphia (USA)'s LLY Position: Q3 2023 in Review

Delphia (USA) sold out of Eli Lilly (LLY) in Q3 2023, closing a stake of 1,319 shares — an estimated $619K sold.

Delphia (USA) first reported a position in LLY in Q4 2021 and held it in 7 quarters. The position peaked at $988K in Q2 2022. 2,975 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • Delphia (USA) reported no remaining Eli Lilly position as of Q3 2023 after selling out during the quarter.
  • Delphia (USA) sold 1,319 Eli Lilly shares in Q3 2023, an estimated $619K.
  • Delphia (USA) first reported a position in Eli Lilly in Q4 2021 and held it in 7 quarters.
  • Delphia (USA)'s Eli Lilly position peaked at $988K in Q2 2022.
  • 2,975 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on Delphia (USA)'s 13F filing for Q3 2023, filed 15 Nov 2023.